Keymed Biosciences (2162.HK) Q3 2024 Earnings

27AugConfirmed
Q2 2023
Q1 2024
Q3 2024
-1.71
-1.6
-1.49
-1.38

Details

Expected EPS
N/A
Actual EPS
-1.384329241212
Surprise EPS
-1.38
Surprise Percent
+∞%

Description

Keymed Biosciences (2162.HK) has reported earnings of -1.384329241212 per share for Q3 2024.

0 Comments

Share your thoughts